Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS

Choi, Young Sik; Choi, Jae Woo

doi:10.1186/s12933-020-01032-5

Cited by 29 publications

(16 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nature exposure during lockdown has been associated with reduced sleep disturbance (Table 2). Inadequate sleep and sleep disturbances are considered common risk factors for several mental and physical illnesses such as obesity, cancer and cardiovascular diseases (Shin et al, 2020;Choi and Choi, 2020;Muscogiuri et a., 2019;Shankar et al, 2010). Spano et al (2021) and Corley et al (2021) indicated that nature exposure, such as viewing nature through windows and gardening during the lockdowns, was negatively associated with sleep disturbance.…”

Section: Sleepmentioning

confidence: 99%

Nature’s contributions in coping with a pandemic in the 21st century: A narrative review of evidence during COVID-19

Labib¹,

Browning²,

Rigolon³

et al. 2021

Preprint

View full text Add to dashboard Cite

While COVID-19 lockdowns have slowed coronavirus transmission, such structural measures also have unintended consequences on mental and physical health. Growing evidence shows that exposure to the natural environment (e.g., blue-green spaces) can improve human health and wellbeing. In this narrative review, we synthesized the evidence about nature’s contributions to health and wellbeing during the first year of the COVID-19 pandemic. We found that during lockdowns, people experienced multiple types of nature, including both outdoors and indoors. Frequency of visits to outdoor natural areas (i.e., public parks) depended on lockdown severity and socio-cultural contexts. Other forms of nature exposure, such as spending time in private gardens and viewing outdoor greenery from windows, may have increased. The majority of the evidence suggests nature exposure during lockdowns was associated with less depression, anxiety, stress, and more happiness and life satisfaction. Additionally, nature exposure was correlated with less physical inactivity and fewer sleep disturbances. Evidence was mixed regarding associations between nature exposure and COVID-related health outcomes, while nature visits might be associated with greater rates of COVID-19 transmission and mortality when proper social distancing measures were not maintained. Findings on whether nature exposure during lockdowns helped ameliorate health inequities by, for example, impacting the health of lower-socioeconomic populations more than their higher-socioeconomic counterparts, were mixed. Based on these findings, we argue that nature exposure may have buffered the negative mental and behavioral impacts of lockdowns during the first year of the COVID-19 pandemic. Recovery and resilience during the current and future public health crises might be improved with nature-based solutions, interventions, designs, and governance.

show abstract

Section: Sleepmentioning

confidence: 99%

Nature’s contributions in coping with a pandemic in the 21st century: A narrative review of evidence during COVID-19

Labib¹,

Browning²,

Rigolon³

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…In a large cohort of adults from the USA, risk of mortality in type 2 diabetes mellitus patients (compared to non-diabetics) increased from 1.84 with a sleep duration of 7 h to 2.78 and 3.67 for 5 and 10 h respectively [13]. Similarly, data from the Korean National health insurance program found that newly diagnosed type 2 diabetes mellitus patients with sleep disturbances have a higher incidence of cardiovascular disease and all-cause mortality [14]. Poor sleep quality has also been shown to be associated with microvascular complications such as diabetic retinopathy [15].…”

mentioning

confidence: 94%

Sleep: an emerging therapeutic target in diabetes care

Raizada

Madhu

2021

Int J Diabetes Dev Ctries

View full text Add to dashboard Cite

“…It is important for persons with type 2 diabetes (T2D) because they are susceptible to developing micro- and macro-vascular diseases [ 17 ], and sleep disorders affect blood sugar and insulin levels [ 18 , 19 ]. A recent study reported sleep disturbance is significantly associated with an increased risk of CVD and all-cause mortality in patients with new-onset T2D [ 20 ], and a long sleep duration (≥ 9 h/day) has been shown to be associated with an increased all-cause mortality in persons with T2D [ 21 ]. A higher level of HbA1c can be found in patients with diabetes with short and long sleep durations than in those with medium sleep duration [ 22 ].…”

Section: Introductionmentioning

confidence: 99%

Sleep duration predicts subsequent long-term mortality in patients with type 2 diabetes: a large single-center cohort study

Lin

Liu

et al. 2022

Cardiovasc Diabetol

View full text Add to dashboard Cite

Background Sleep duration is associated with mortality. However, prior studies exploring whether sleep duration predicts subsequent long-term mortality in patients with diabetes are limited. This study aims to examine whether metabolic factors affect the associations between baseline sleep duration and subsequent risks of all-cause, expanded, and non-expanded cardiovascular disease (CVD) mortalities among patients with type 2 diabetes (T2D). Methods A total of 12,526 T2D patients aged 30 years and older, with a follow-up period ≥ 3 years, were identified from the Diabetes Case Management Program of a medical center in Taiwan. Sleep duration was measured using computerized questionnaires by case managers, and the time frame for this question was 1 month prior to the interview date. Sleep duration in relation to subsequent mortality from all causes, expanded CVD, and non-expanded CVD was examined using Cox proportional hazard models. Results Within 10 years of follow-up, 2918 deaths (1328 CVD deaths and 1590 non-CVD deaths) were recorded. A J-shaped association was observed for all-cause, expanded CVD, and non-expanded CVD mortalities, and the lowest risks were observed for patients with 5–7 h of sleep. The significant joint effects included sleep duration of more or less than 7 h with age ≥ 65 years [adjusted HRs: 4.00 (3.49–4.60)], diabetes duration ≥ 5 years [1.60 (1.40–1.84)], age at diabetes diagnosis ≤ 45 years [1.69 (1.38–2.07)], insulin use [1.76 (1.54–2.03)], systolic blood pressure/diastolic blood pressure > 130/85 mmHg [1.24 (1.07–1.43)], triglyceride ≥ 150 mg/dL [1.38 (1.22–1.56)], HbA1c ≥ 7% [1.31 (1.13–1.52)], and body mass index < 27 kg/m2 [1.31 (1.17–1.45)] for all-cause mortality. Conclusion A J-shaped association was observed between sleep duration and all-cause and expanded CVD mortality, and a sleep duration of 5–7 h had the lowest mortality risk. Sleep duration also showed significant synergistic interactions with diabetes duration but shared an antagonistic interaction with age and obesity.

show abstract

Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS

Cited by 29 publications

References 36 publications

Nature’s contributions in coping with a pandemic in the 21st century: A narrative review of evidence during COVID-19

Nature’s contributions in coping with a pandemic in the 21st century: A narrative review of evidence during COVID-19

Sleep: an emerging therapeutic target in diabetes care

Sleep duration predicts subsequent long-term mortality in patients with type 2 diabetes: a large single-center cohort study

Contact Info

Product

Resources

About